Publicaciones en colaboración con investigadores/as de Maastricht University Medical Centre (2)

2023

  1. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

    Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644

2021

  1. Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study

    CNS Drugs, Vol. 35, Núm. 9, pp. 1009-1022